SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-039306
Filing Date
2024-04-01
Accepted
2024-04-01 16:05:42
Documents
76
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atos-20231231.htm   iXBRL 10-K 2166385
2 EX-10.12 atos-ex10_12.htm EX-10.12 109656
3 EX-10.13 atos-ex10_13.htm EX-10.13 16537
4 EX-21.1 atos-ex21_1.htm EX-21.1 1486
5 EX-23.1 atos-ex23_1.htm EX-23.1 6620
6 EX-23.2 atos-ex23_2.htm EX-23.2 6077
7 EX-31.1 atos-ex31_1.htm EX-31.1 12834
8 EX-31.2 atos-ex31_2.htm EX-31.2 13133
9 EX-32.1 atos-ex32_1.htm EX-32.1 7697
10 EX-32.2 atos-ex32_2.htm EX-32.2 8707
11 EX-97.1 atos-ex97_1.htm EX-97.1 32490
12 GRAPHIC img83880236_0.jpg GRAPHIC 353219
13 GRAPHIC img95494516_0.jpg GRAPHIC 127928
  Complete submission text file 0000950170-24-039306.txt   7971380

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atos-20231231.xsd EX-101.SCH 1023168
80 EXTRACTED XBRL INSTANCE DOCUMENT atos-20231231_htm.xml XML 866023
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35610 | Film No.: 24809129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)